• FirefoxInstall the new Firefox »
  •  Dow Up 1.49% Nasdaq Up 1.15%

    BioMarin Pharmaceutical Inc. (BMRN)

    -NasdaqGS
    129.20 Up 0.42(0.33%) 3:59PM EDT
    |After Hours : 129.13 Down 0.07 (0.05%) 4:00PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:128.78
    Open:131.33
    Bid:129.25 x 200
    Ask:129.31 x 100
    1y Target Est:123.63
    Beta:1.14
    Earnings Date:Apr 29 - May 4 (Est.)
    Day's Range:126.54 - 133.44
    52wk Range:55.04 - 133.54
    Volume:2,729,028
    Avg Vol (3m):1,515,540
    Market Cap:20.56B
    P/E (ttm):N/A
    EPS (ttm):-0.92
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for BMRN

    Comparison

    Symbol% ChgMkt Cap
    BMRNUp 0.33%20.56B
    FOLDUp 0.05%1.05B
    SHPGUp 0.44%47.35B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):27.29
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-2.29
    Quarterly EPS Est (Mar-15) :-0.53
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-2.02

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback